initial public offerings (IPOs) trading on American exchanges

Friday, September 30, 2016

Nutanix (NTNX) began trading on Nasdaq on 30 Sept 2016

  • Lockup Period (days)‎: ‎180
  • Quiet Period Expiration‎: ‎11/9/2016
  • Share Price‎: ‎$16.00
  • Shares Offered‎: ‎14,870,000

Key stats and ratios

Q1 (Jan '17)2016
Net profit margin-51.16%-37.87%
Operating margin-50.65%-37.09%
EBITD margin--31.15%
Return on average assets-56.69%-51.93%
Return on average equity-246.34%-


1740 Technology Dr Ste 150
SAN JOSE, CA 95110-1348
United States 

Nutanix shares more than doubled in their first day of trading on Friday, the strongest first-day gain for a new technology stock offering so far this year.

The company, a provider of cloud-based storage for businesses, waited nine months for its initial public stock offering as choppy markets kept many other private companies away. Nutanix was one of the few venture capital-backed start-ups brave enough to file plans for its initial offering last year. Shares surged 66 percent at the open of trading and finished the day up 131 percent.

So far in 2016, 17 tech companies have listed in the United States, the lowest number since 11 deals in 2009, according to data from Dealogic. Before Nutanix, this year’s new listings were trading an average of 72 percent above their offer prices, compared with an average of 35 percent across all sectors for domestic initial public offerings. Nutanix’s gain beats that of the cloud communications provider Twilio, which jumped 92 percent on its first day in June.

The pop suggests that investors are still eager for hot tech offerings after all. After much anticipation, Nutanix priced its $238 million offering Thursday evening, with a valuation of $2.18 billion — slightly higher than the one it received in the private markets two and a half years ago.

Although Nutanix did not receive the large premium that its latest investors would have liked, the company, which was founded seven years ago, avoided the fate feared by others of pricing shares at a steep discount to their most recent private funding round. Nutanix’s shares are listed on Nasdaq under the ticker symbol NTNX.

Thursday, September 29, 2016

Alcobra (ADHD) tumbles on FDA clinical hold

Alcobra (ADHD) announced late yesterday that the FDA has placed a clinical hold on its new drug applications for MDX for ADHD treatment.

Alcobra Ltd. (ADHD) saw its shares get halved on Thursday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on its late-stage trial. Specifically, the Division of Psychiatry Products gave a verbal notice that a full clinical hold had been placed on its Investigational New Drug applications for MDX in attention-deficit/hyperactivity disorder (ADHD) and fragile X syndrome.

The clinical hold affects Alcobra’s ongoing Phase 3 clinical study of MDX in adult patients with ADHD, known as the “MEASURE” study.

The company has not yet received written notice of the clinical hold from the FDA, however, based on verbal communications, the FDA indicated that the clinical hold is due to adverse neurological findings in a pre-clinical study.

The FDA notification was not based on clinical safety data observed in the ongoing MEASURE study, which has enrolled nearly 500 subjects, or previous clinical studies involving MDX.

Alcobra said that it plans to work diligently with the FDA to seek the removal of the clinical hold.

Excluding Thursday’s move, Alcobra has underperformed the broad markets, with the stock down about 26% year to date. Over the past 52 weeks, the stock is down about 22%.

Wednesday, September 21, 2016

Novan (NOVN) started trading on the Nasdaq on 21 September 2016

  • Novan (NOVN) priced its IPO of 4.1M shares (up from 3.75M) at $11. 
  • Underwriters over-allotment is an additional 615K shares.
  • Novan developes nitric oxide-based therapies used in dermatology.
  • Was founded in 2006 and is headquartered in Durham, North Carolina.


Company Overview

Company NameNOVAN, INC.
Company Address4105 HOPSON ROAD
Company Phone919-485-8080
CEONathan Stasko
Employees (as of 6/30/2016)63
State of IncDE
Fiscal Year End12/31
StatusPriced (9/21/2016)
Proposed SymbolNOVN
ExchangeNASDAQ Global
Share Price$11.00
Shares Offered4,100,000
Offer Amount$45,100,000.00
Total Expenses$2,399,892.00
Shares Over Alloted0
Shareholder Shares Offered--
Shares Outstanding15,323,659
Lockup Period (days)180
Lockup Expiration3/20/2017
Quiet Period Expiration10/31/2016

Monday, September 19, 2016

Infoblox (BLOX) to be acquired by Vista Equity Partners

  • Infoblox (BLOX) to be acquired by private equity firm Vista Equity Partners for $1.6 billion or $26.50 per share. (19 Sept 2016)